Identifying roles of “Jun-Chen-Zuo-Shi” component herbs of QiShenYiQi formula in treating acute myocardial ischemia by network pharmacology

BackgroundThe role of “Jun-Chen-Zuo-Shi” (also known as “sovereign-minister-assistant-courier”) component herbs of Chinese medicine is not fully understood. This study aims to test the “Jun-Chen-Zuo-Shi” rule with the QiShenYiQi formula (QSYQ) on treating acute myocardial ischemia (AMI) by a network pharmacology approach.MethodsAn Acute Myocardial Ischemia (AMI) specific Organism Disturbed Network (AMI-ODN), was constructed by integrating data of disease-associated genes, protein-protein interaction and microarray experiments. A network-based index, Network Recovery Index for Organism Disturbed Network (NRI-ODN), was developed to measure the therapeutic efficacy of QSYQ and its ingredients, i.e., the ability to recover disturbed AMI network model back to normal state.ResultsThe whole formula of QSYQ got a NRI-ODN score of 864.48, which outperformed all individual herbs. Additionally, the primary component herbs, Radix Astragalus membranaceus and Radix Salvia miltiorrrhiza showed NRI-DON score of 680.27 and 734.31 respectively, which meant a better performance to recover disturbed AMI network than the supplementary component herbs, Panax notoginseng and Dalbergia sissoo did (545.76 and 584.88, respectively).ConclusionAMI-ODN model and NRI-ODN identified the possible roles of “Jun-Chen-Zuo-Shi” component herbs of QSYQ in treating AMI at molecular network and pathway level.

[1]  E. De Clercq.  Perspectives of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection. , 1999, Farmaco.

[2]  Trey Ideker,et al.  Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..

[3]  Sandhya Rani,et al.  Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..

[4]  M. Pfeffer,et al.  Myocardial Infarct Size and Ventricular Function in Rats , 1979, Circulation research.

[5]  Wei Liu,et al.  Astragaloside IV, a Novel Antioxidant, Prevents Glucose-Induced Podocyte Apoptosis In Vitro and In Vivo , 2012, PloS one.

[6]  Peiying Shi,et al.  Metabolite profiling and pharmacokinetics of herbal compounds following oral administration of a cardiovascular multi-herb medicine (Qishen yiqi pills) in rats. , 2012, Current drug metabolism.

[7]  Melinda R. Dwinell,et al.  The Rat Genome Database 2009: variation, ontologies and pathways , 2008, Nucleic Acids Res..

[8]  S. Akira,et al.  Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.

[9]  Xiang Li,et al.  Dissecting active ingredients of Chinese medicine by content-weighted ingredient-target network. , 2014, Molecular bioSystems.

[10]  L. Magnelli,et al.  Complex interplay among apoptosis factors: RB, p53, E2F, TGF-beta, cell cycle inhibitors and the bcl2 gene family. , 1997, Pharmacological research.

[11]  D. Bohr,et al.  Vascular smooth muscle function and its changes in hypertension. , 1984, The American journal of medicine.

[12]  M. Kastan,et al.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C. Visser,et al.  Apoptosis in myocardial ischaemia and infarction , 2002, Journal of clinical pathology.

[14]  Xiang Li,et al.  CHD@ZJU: a knowledgebase providing network-based research platform on coronary heart disease , 2013, Database J. Biol. Databases Curation.

[15]  Yi Wang,et al.  A Network Pharmacology Approach to Evaluating the Efficacy of Chinese Medicine Using Genome-Wide Transcriptional Expression Data , 2013, Evidence-based complementary and alternative medicine : eCAM.

[16]  Bo Zhang,et al.  Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae , 2010, BMC Bioinform..

[17]  N. Frangogiannis,et al.  The role of TGF-β Signaling in Myocardial Infarction and Cardiac Remodeling , 2007 .

[18]  Weiren Xu,et al.  Effects of Astragaloside IV on heart failure in rats , 2009, Chinese medicine.

[19]  Shao Li,et al.  A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study. , 2014, Molecular bioSystems.

[20]  Zhi-xiang Shen,et al.  Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia , 2008, Proceedings of the National Academy of Sciences.

[21]  Yiyu Cheng,et al.  A pre-classification strategy for identification of compounds in traditional Chinese medicine analogous formulas by high-performance liquid chromatography-Mass spectrometry. , 2014, Journal of pharmaceutical and biomedical analysis.

[22]  Wei Liu,et al.  A Network Pharmacology Study of Chinese Medicine QiShenYiQi to Reveal Its Underlying Multi-Compound, Multi-Target, Multi-Pathway Mode of Action , 2014, PloS one.

[23]  Wei Liu,et al.  A Network Study of Chinese Medicine Xuesaitong Injection to Elucidate a Complex Mode of Action with Multicompound, Multitarget, and Multipathway , 2013, Evidence-based complementary and alternative medicine : eCAM.

[24]  K. Mattock,et al.  Chinese medicine. , 1976, The Australasian nurses journal.

[25]  R. Strieter,et al.  Chemokine signaling in inflammation , 2000, Critical care medicine.

[26]  Bo Zhang,et al.  Network target for screening synergistic drug combinations with application to traditional Chinese medicine , 2011, BMC Systems Biology.

[27]  Mike Tyers,et al.  BioGRID: a general repository for interaction datasets , 2005, Nucleic Acids Res..

[28]  Yiyu Cheng,et al.  A Three Step Network Based Approach (TSNBA) to Finding Disease Molecular Signature and Key Regulators: A Case Study of IL-1 and TNF-Alpha Stimulated Inflammation , 2014, PloS one.

[29]  Lingyan Yu,et al.  QI-SHEN-YI-QI accelerates angiogenesis after myocardial infarction in rats. , 2010, International journal of cardiology.

[30]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .